Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Memory | 4 | 2018 | 225 | 1.480 |
Why?
|
| Speech Perception | 4 | 2016 | 71 | 1.220 |
Why?
|
| Hypertension | 2 | 2021 | 1141 | 0.820 |
Why?
|
| Visual Perception | 4 | 2016 | 319 | 0.820 |
Why?
|
| Noncommunicable Diseases | 1 | 2021 | 5 | 0.800 |
Why?
|
| Phonetics | 3 | 2010 | 36 | 0.690 |
Why?
|
| Aging | 2 | 2013 | 691 | 0.640 |
Why?
|
| Association Learning | 1 | 2018 | 34 | 0.630 |
Why?
|
| Speech Acoustics | 2 | 2010 | 22 | 0.620 |
Why?
|
| Chronic Disease | 1 | 2021 | 971 | 0.610 |
Why?
|
| Sound | 1 | 2017 | 26 | 0.610 |
Why?
|
| Color | 1 | 2017 | 81 | 0.590 |
Why?
|
| Speech | 1 | 2016 | 84 | 0.560 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 132 | 0.540 |
Why?
|
| Life Expectancy | 1 | 2013 | 86 | 0.460 |
Why?
|
| Memory Disorders | 1 | 2013 | 69 | 0.440 |
Why?
|
| Crime | 1 | 2013 | 36 | 0.440 |
Why?
|
| Cognition | 1 | 2017 | 570 | 0.430 |
Why?
|
| Students | 1 | 2013 | 147 | 0.420 |
Why?
|
| Terminal Care | 1 | 2013 | 130 | 0.420 |
Why?
|
| Empathy | 1 | 2013 | 147 | 0.410 |
Why?
|
| Young Adult | 7 | 2020 | 5976 | 0.400 |
Why?
|
| Hospitals, District | 2 | 2021 | 2 | 0.390 |
Why?
|
| Uganda | 2 | 2021 | 34 | 0.390 |
Why?
|
| Auditory Pathways | 1 | 2010 | 33 | 0.380 |
Why?
|
| Rural Population | 2 | 2021 | 136 | 0.360 |
Why?
|
| Cues | 2 | 2010 | 175 | 0.360 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 6509 | 0.330 |
Why?
|
| Learning | 1 | 2010 | 280 | 0.300 |
Why?
|
| Age Factors | 3 | 2018 | 1851 | 0.280 |
Why?
|
| Delivery of Health Care | 2 | 2021 | 426 | 0.270 |
Why?
|
| Quality of Life | 1 | 2013 | 1585 | 0.270 |
Why?
|
| Adult | 10 | 2021 | 25648 | 0.240 |
Why?
|
| Acoustic Stimulation | 2 | 2017 | 130 | 0.240 |
Why?
|
| Aged | 6 | 2021 | 18415 | 0.230 |
Why?
|
| Adolescent | 5 | 2018 | 8981 | 0.230 |
Why?
|
| Male | 9 | 2021 | 40965 | 0.210 |
Why?
|
| Female | 14 | 2021 | 44532 | 0.210 |
Why?
|
| Photic Stimulation | 2 | 2017 | 493 | 0.210 |
Why?
|
| Humans | 22 | 2021 | 86643 | 0.200 |
Why?
|
| Community Health Workers | 1 | 2021 | 26 | 0.190 |
Why?
|
| Personnel Turnover | 1 | 2020 | 7 | 0.190 |
Why?
|
| Treatment Adherence and Compliance | 1 | 2020 | 5 | 0.190 |
Why?
|
| Knowledge | 1 | 2020 | 29 | 0.190 |
Why?
|
| Middle Aged | 5 | 2021 | 25028 | 0.180 |
Why?
|
| Attention | 1 | 2003 | 388 | 0.170 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 162 | 0.170 |
Why?
|
| Risk | 1 | 2020 | 674 | 0.160 |
Why?
|
| Neoplasms | 1 | 2013 | 2898 | 0.160 |
Why?
|
| Cohort Effect | 1 | 2017 | 6 | 0.150 |
Why?
|
| Semantics | 1 | 2017 | 50 | 0.150 |
Why?
|
| Mental Recall | 1 | 2018 | 159 | 0.140 |
Why?
|
| Blood Pressure | 1 | 2021 | 1143 | 0.130 |
Why?
|
| Judgment | 1 | 2013 | 64 | 0.110 |
Why?
|
| Reaction Time | 1 | 2013 | 309 | 0.100 |
Why?
|
| Psychoacoustics | 1 | 2010 | 10 | 0.100 |
Why?
|
| Digestive System | 1 | 1990 | 42 | 0.100 |
Why?
|
| Audiometry | 1 | 2010 | 16 | 0.100 |
Why?
|
| Signal Detection, Psychological | 1 | 2010 | 20 | 0.100 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 502 | 0.100 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1989 | 100 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2010 | 482 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 1989 | 579 | 0.070 |
Why?
|
| Esophageal Neoplasms | 1 | 1989 | 321 | 0.070 |
Why?
|
| Crohn Disease | 1 | 1990 | 730 | 0.060 |
Why?
|
| Sound Spectrography | 1 | 2003 | 19 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 1989 | 621 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 1989 | 744 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1989 | 1076 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 1993 | 2262 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 1989 | 1939 | 0.030 |
Why?
|
| Chordoma | 1 | 1993 | 19 | 0.030 |
Why?
|
| Sacrum | 1 | 1993 | 40 | 0.030 |
Why?
|
| Abetalipoproteinemia | 1 | 1991 | 2 | 0.030 |
Why?
|
| Jugular Veins | 1 | 1992 | 69 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 1991 | 38 | 0.030 |
Why?
|
| Cryopreservation | 1 | 1992 | 69 | 0.030 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 1991 | 6 | 0.030 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 1991 | 8 | 0.030 |
Why?
|
| Duodenum | 1 | 1990 | 100 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1990 | 94 | 0.020 |
Why?
|
| Fatty Acids | 1 | 1991 | 130 | 0.020 |
Why?
|
| Esophagus | 1 | 1990 | 102 | 0.020 |
Why?
|
| Stomach | 1 | 1990 | 108 | 0.020 |
Why?
|
| Chromosome Disorders | 1 | 1990 | 114 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 1990 | 364 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1992 | 228 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1990 | 141 | 0.020 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1990 | 127 | 0.020 |
Why?
|
| Adenofibroma | 1 | 1989 | 5 | 0.020 |
Why?
|
| Aneuploidy | 1 | 1989 | 55 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1990 | 153 | 0.020 |
Why?
|
| Cystadenocarcinoma | 1 | 1989 | 12 | 0.020 |
Why?
|
| Intestine, Small | 1 | 1991 | 303 | 0.020 |
Why?
|
| Liver | 2 | 1991 | 1230 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1990 | 286 | 0.020 |
Why?
|
| Urethral Diseases | 1 | 1989 | 15 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1990 | 387 | 0.020 |
Why?
|
| Diverticulum | 1 | 1989 | 44 | 0.020 |
Why?
|
| Esophageal Diseases | 1 | 1988 | 26 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 1990 | 325 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1990 | 261 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 1989 | 552 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1989 | 486 | 0.020 |
Why?
|
| Barrett Esophagus | 1 | 1988 | 93 | 0.020 |
Why?
|
| Gene Expression | 1 | 1991 | 1284 | 0.020 |
Why?
|
| Biopsy | 1 | 1990 | 1163 | 0.020 |
Why?
|
| Carcinoma | 1 | 1989 | 436 | 0.020 |
Why?
|
| Colon | 1 | 1989 | 496 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1990 | 3612 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1993 | 2438 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1989 | 1169 | 0.010 |
Why?
|
| Prognosis | 1 | 1989 | 3679 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2002 | 157 | 0.010 |
Why?
|
| Child | 1 | 1990 | 6927 | 0.010 |
Why?
|
| Epithelium | 2 | 1989 | 319 | 0.010 |
Why?
|
| Forelimb | 1 | 1992 | 17 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1992 | 135 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 274 | 0.010 |
Why?
|
| Apolipoproteins | 1 | 1991 | 38 | 0.010 |
Why?
|
| Vascular Patency | 1 | 1992 | 126 | 0.010 |
Why?
|
| Veins | 1 | 1992 | 94 | 0.010 |
Why?
|
| Palmitates | 1 | 1991 | 18 | 0.010 |
Why?
|
| Carnitine | 1 | 1991 | 14 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1992 | 234 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1991 | 92 | 0.010 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1990 | 19 | 0.010 |
Why?
|
| Dogs | 1 | 1992 | 685 | 0.010 |
Why?
|
| Triglycerides | 1 | 1991 | 232 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1993 | 322 | 0.010 |
Why?
|
| Aspirin | 1 | 1992 | 156 | 0.010 |
Why?
|
| Muscles | 1 | 1991 | 194 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 503 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1991 | 376 | 0.010 |
Why?
|
| Ki-1 Antigen | 1 | 1990 | 17 | 0.010 |
Why?
|
| Karyotyping | 1 | 1990 | 250 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1991 | 373 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1990 | 231 | 0.010 |
Why?
|
| Cholesterol | 1 | 1991 | 356 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1992 | 996 | 0.010 |
Why?
|
| Metaplasia | 1 | 1989 | 37 | 0.010 |
Why?
|
| Cell Division | 1 | 1990 | 696 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1990 | 458 | 0.010 |
Why?
|
| Ulcer | 1 | 1988 | 36 | 0.010 |
Why?
|
| Myocardium | 1 | 1991 | 529 | 0.000 |
Why?
|
| Esophagoscopy | 1 | 1988 | 87 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1990 | 729 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1990 | 666 | 0.000 |
Why?
|
| Base Sequence | 1 | 1991 | 2330 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1993 | 1313 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1991 | 3030 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1992 | 746 | 0.000 |
Why?
|
| Gastroesophageal Reflux | 1 | 1988 | 117 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1992 | 1065 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1991 | 1981 | 0.000 |
Why?
|
| Infant | 1 | 1991 | 3046 | 0.000 |
Why?
|
| Phenotype | 1 | 1990 | 2378 | 0.000 |
Why?
|
| Liver Transplantation | 1 | 1991 | 1268 | 0.000 |
Why?
|
| Animals | 1 | 1992 | 26582 | 0.000 |
Why?
|